Company: ARWR
Filing Date: 2025-10-10
Form Type: 10-K/A
Source: 0000879407-25-000013
Chunk: 39

Company: ARROWHEAD PHARMACEUTICALS, INC.
Filing Date: 2025-10-10
Form: 10-K/A
Chunk 39
---
        |     |                |             |
| Cash Bonus           |     |            |     |                  $195,552 |     |             |     |            |     | —                                                   |         |     |               — |        |     | —              |             |
| RSUs                 |     | 01/04/2024 |     |                         — |     |             |     |            |     | —                                                   |         |     |                 | 75,000 |     |                |  $2,589,750 |

(1) Amounts listed represent cash award targets for our NEOs in fiscal 2024. Actual payments were made in fiscal 2025 and the amounts are reported in the Summary Compensation Table above. There are no thresholds or maximum levels applicable under our annual cash incentive awards except with respect to Dr. Anzalone, whose target opportunity is capped at 150%.

(2) These PRSUs are described above in the “Compensation Discussion and Analysis” under the heading “Equity Compensation.”

(3) RSUs granted in fiscal 2024 vest in four equal annual installments beginning 1 year from the grant date.

(4) Dr. San Martin and Ms. Oliver forfeited their fiscal 2024 equity awards upon their respective departures.

Fiscal 2024 Outstanding Equity Awards at Fiscal Year End Table

The following table provides information, with respect to the NEOs, concerning the outstanding equity awards covering shares of the Company’s common stock as of September 30, 2024.

|                      |     |       |     |            |     | Stock Awards                    |   |        |     |                        |           |   |     |                                                                   |     |         |     |   |                                       |            |   |
| Name                 |     | Grant 
 Date  |     |            |     | Number ofShares orUnits ofStock 
 ThatHave NotVested              
 (#) (1)                         |   |        |     | Market                 
 Value of               
 Shares orUnits ofStock 
 ThatHave               
 NotVested              
 ($) (2)                |           |   |     | EquityIncentivePlanAwards:Number ofUnearnedShares orUnits ofStock 
 ThatHave                                                          
 NotVested                                                         
 (#) (3)                                                           |     |         |     |   | EquityIncentivePlanAwards:Market      
 ValueofUnearnedShares orUnits ofStock 
 ThatHave                              
 NotVested($) (2)                      |            |   |